iBio, Inc. (IBIO) shareholders
Close on Nov 17, 2026Market cap $48.11MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Point72 Capital Advisors, Inc. Joint filing with Point72 Asset Management, L.P. (9.90%), Steven A. Cohen (9.90%) | 14,289,118 | 9.90% | 13G (passive) | Aug 22, 2025 |
| Alex Silverstein Joint filing with Sirenia Capital Management LP (9.90%) | 11,586,340 | 9.90% | 13G (passive) | Mar 31, 2026 |
| Coastlands Capital LP Joint filing with Coastlands Capital Partners LP (9.72%), Coastlands Capital GP LLC (9.72%) and 2 more | 6,247,738 | 9.72% | 13G (passive) | Oct 7, 2026 |
| Cormorant Asset Management, LP Joint filing with Bihua Chen (9.99%) | 5,117,481 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| Affinity Asset Advisors, LLC Joint filing with Michael Cho (9.99%) | 5,068,882 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| Ryan Wilder Joint filing with Vestal Point Capital, LP (9.90%) | 4,275,000 | 9.90% | 13G (passive) | Sep 30, 2025 |
| Vestal Point Capital, LP Joint filing with Ryan Wilder (7.90%) | 4,025,000 | 7.90% | 13G (passive) amendment | Jun 30, 2026 |
| Weston Nichols Joint filing with Lynx1 Capital Management LP (5.40%) | 2,807,016 | 5.40% | 13G (passive) | Jun 30, 2026 |
| Michael Cho Joint filing with Affinity Asset Advisors, LLC (9.99%) | 2,401,616 | 9.99% | 13G (passive) amendment | Jan 22, 2026 |
| Oleg Nodelman Joint filing with EcoR1 Capital, LLC (9.90%), EcoR1 Capital Fund Qualified, L.P. (9.30%) | 2,228,000 | 9.90% | 13G (passive) | Dec 10, 2025 |
| SilverArc Capital Management, LLC Joint filing with Devesh Gandhi (9.99%), SilverArc Capital Alpha Fund II, L.P. (7.15%) | 2,181,422 | 9.99% | 13G (passive) | Sep 30, 2025 |
| Phillip Gross Joint filing with Adage Capital Management, L.P. (9.99%), Robert Atchinson (9.99%) | 2,181,422 | 9.99% | 13G (passive) | Sep 30, 2025 |
| Logos Global Master Fund LP Joint filing with Logos Global Management LP (8.90%), Logos Global Management GP LLC (8.90%) and 2 more | 2,000,000 | 8.90% | 13G (passive) | Dec 12, 2025 |
| Fhmlsp, L.P. Joint filing with Frazier Life Sciences Public Fund, L.P. (5.70%), Fhmlsp, L.L.C. (5.70%) | 1,953,467 | 5.70% | 13G (passive) amendment | Mar 31, 2026 |
| Fhmlsp, L.L.C. Joint filing with Frazier Life Sciences Public Fund, L.P. (8.70%), Fhmlsp, L.P. (8.70%) | 1,953,467 | 8.70% | 13G (passive) | Dec 9, 2025 |
| Israel A. Englander Joint filing with Millennium Management LLC (5.20%), Millennium Group Management LLC (5.20%) and 1 more | 1,235,827 | 5.20% | 13G (passive) | Jan 15, 2026 |
| ADAR1 Capital Management GP, LLC Joint filing with ADAR1 Capital Management, LLC (9.99%), Daniel Schneeberger (9.99%) | 1,095,967 | 9.99% | 13G (passive) amendment | Dec 31, 2024 |
| ADAR1 Partners, LP Joint filing with ADAR1 Capital Management, LLC (9.27%), ADAR1 Capital Management GP, LLC (9.27%) and 1 more | 789,293 | 9.27% | 13G (passive) | Mar 26, 2024 |
| Opaleye Management, Inc. | 750,000 | 7.60% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IBIO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 4,007,881 | 6.23% | $7.01M | +900,681 | 0.32% |
| Cormorant Asset Management, LP | 3,570,000 | 5.55% | $6.25M | New | 0.32% |
| Silverarc Capital Management, LLC | 3,520,490 | 5.47% | $6.16M | +3,294,490 | 0.64% |
| Vestal Point Capital, LP | 2,600,000 | 4.04% | $4.55M | New | 0.11% |
| Vanguard Capital Management LLC | 2,098,151 | 3.26% | $3.67M | +1,009,852 | 0.00% |
| Frazier Life Sciences Management, L.P. | 1,953,467 | 3.04% | $3.42M | – | 0.07% |
| Ensign Peak Advisors, Inc | 1,832,457 | 2.85% | $3.21M | New | 0.01% |
| Woodline Partners LP | 1,776,547 | 2.76% | $3.11M | New | 0.01% |
| Millennium Management LLC | 1,651,473 | 2.57% | $2.89M | +101,623 | 0.00% |
| Citadel Advisors LLC | 1,384,029 | 2.15% | $2.42M | +427,600 | 0.00% |
| Balyasny Asset Management L.P. | 1,170,893 | 1.82% | $2.05M | +159,938 | 0.00% |
| Bank Of America Corp /De/ | 1,121,492 | 1.74% | $1.96M | +831,079 | 0.00% |
| Ikarian Capital, LLC | 957,062 | 1.49% | $1.67M | – | 0.18% |
| Sio Capital Management, LLC | 904,268 | 1.41% | $1.58M | – | 0.26% |
| Marshall Wace, Llp | 904,132 | 1.41% | $1.58M | +283,530 | 0.00% |
| Geode Capital Management, LLC | 500,816 | 0.78% | $876.65K | +113,249 | 0.00% |
| Walleye Capital LLC | 500,375 | 0.78% | $875.66K | +111,821 | 0.00% |
| Squarepoint Ops LLC | 498,872 | 0.78% | $873.03K | New | 0.00% |
| Noesis Capital Mangement Corp | 405,000 | 0.63% | $708.75K | +93,500 | 0.09% |
| Two Sigma Investments, LP | 400,667 | 0.62% | $701.17K | −8,191 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 55 | 35M | 54.0% | 16 / 22 | 9 / 12 | 19M | 4M |
| Q1 2026 | 52 | 19M | 30.2% | 16 / 16 | 8 / 12 | 8M | 4M |
| Q4 2025 | 50 | 16M | 25.4% | 26 / 12 | 4 / 8 | 14M | 2M |
| Q3 2025 | 32 | 4M | 5.6% | 6 / 9 | 6 / 3 | 1M | 1M |
| Q2 2025 | 30 | 3M | 5.0% | 7 / 7 | 2 / 10 | 1M | 0M |
| Q1 2025 | 34 | 3M | 4.0% | 8 / 10 | 2 / 3 | 0M | 0M |
| Q4 2024 | 30 | 3M | 4.1% | 1 / 6 | 7 / 3 | 0M | 0M |
| Q3 2024 | 32 | 3M | 4.1% | 6 / 2 | 6 / 0 | 0M | 0M |
| Q2 2024 | 28 | 3M | 4.2% | 6 / 3 | 11 / 5 | 1M | 1M |
| Q1 2024 | 28 | 3M | 4.5% | 10 / 6 | 4 / 3 | 3M | 0M |
| Q4 2023 | 21 | 0M | 0.4% | 21 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
12 funds held IBIO in Q2 2026, 85% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IBIO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,465,833 | 2.28% | $2.57M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 582,071 | 0.91% | $1.02M | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 187,860 | 0.29% | $356.93K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 103,831 | 0.16% | $181.70K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 63,803 | 0.10% | $121.23K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 51,345 | 0.08% | $97.56K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 29,586 | 0.05% | $51.78K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 20,661 | 0.03% | $36.16K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 19,435 | 0.03% | $36.93K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 6,970 | 0.01% | $12.20K | 0.01% | Jun 30, 2026 |
| Total Stock Market Index Trust | 654 | 0.00% | $1.14K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 500 | 0.00% | $875 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Martin Brenner | See Remarks, Director | 30,652 | 0.05% | Mar 23, 2026 |
| Molly Carr | Chief Medical Officer | – | – | Aug 4, 2026 |
| Marc Banjak | Chief Legal Officer | 25,000 | 0.04% | Mar 27, 2026 |
| Felipe Duran | Chief Financial Officer | 35,974 | 0.06% | Mar 23, 2026 |
| Gary Sender | Director | 9,191 | 0.01% | Oct 15, 2026 |
| Alexandra Kropotova | Director | – | – | Oct 15, 2026 |
| William D. Clark | Director | 1,838 | 0.00% | Oct 15, 2026 |
| David Arkowitz | Director | 18,382 | 0.03% | Oct 15, 2026 |
| Elizabeth Stoner | Director | – | – | Oct 15, 2026 |
| Antonio Bernardino Guimaraes Parada | Director | 183,823 | 0.29% | Oct 15, 2026 |
| Evert B. Schimmelpennink | Director | – | – | Nov 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Marc Banjak Chief Legal Officer | Mar 26, 2026 | Buy | +1,434 | $1.76 | $2.52K | 25,000 |
| Marc Banjak Chief Legal Officer | Mar 26, 2026 | Buy | +12,500 | $1.64 | $20.50K | 23,566 |
| Martin Brenner See Remarks, Director | Mar 19, 2026 | Buy | +12,336 | $2.02 | $24.92K | 30,652 |
| Felipe Duran Chief Financial Officer | Mar 19, 2026 | Buy | +24,835 | $2.02 | $50.17K | 35,974 |
| David Arkowitz Director | Jan 10, 2025 | Buy | +18,382 | $2.72 | $50.00K | 18,382 |
| Martin Brenner See Remarks, Director | Jan 10, 2025 | Buy | +9,191 | $2.72 | $25.00K | 18,316 |
| Felipe Duran Chief Financial Officer | Jan 10, 2025 | Buy | +9,191 | $2.72 | $25.00K | 11,139 |
| Gary Sender Director | Jan 10, 2025 | Buy | +9,191 | $2.72 | $25.00K | 9,191 |
| Antonio Bernardino Guimaraes Parada Director | Jan 10, 2025 | Buy | +183,823 | $2.72 | $500.00K | 183,823 |
| Marc Banjak Chief Legal Officer | Jan 10, 2025 | Buy | +9,191 | $2.72 | $25.00K | 11,066 |
| William D. Clark Director | Jan 10, 2025 | Buy | +1,838 | $2.72 | $5.00K | 1,838 |
| Martin Brenner See Remarks | Nov 1, 2023 | Sale | −4,881 | $0.27 | $1.32K | 182,502 |
| Martin Brenner See Remarks | Oct 3, 2023 | Sale | −5,267 | $0.30 | $1.58K | 187,383 |
| Martin Brenner See Remarks | Oct 2, 2023 | Sale | −4,215 | $0.31 | $1.31K | 192,650 |
| Martin Brenner See Remarks | Aug 28, 2023 | Sale | −5,011 | $0.31 | $1.55K | 196,865 |
| Martin Brenner See Remarks | Jul 27, 2023 | Sale | −4,480 | $0.51 | $2.28K | 201,911 |
| Martin Brenner See Remarks | Jul 27, 2023 | Sale | −35 | $0.51 | $18 | 201,876 |
| Martin Brenner See Remarks | Jul 12, 2023 | Sale | −47,020 | $0.59 | $27.74K | 206,391 |
| Martin Brenner See Remarks | Jun 26, 2023 | Award | +75,833 | – | – | 253,411 |
| Martin Brenner See Remarks | Jun 22, 2023 | Returned to company | −75,833 | – | – | 177,578 |
| Martin Brenner See Remarks | Jun 21, 2023 | Sale | −100 | $0.68 | $68 | 253,411 |
| Martin Brenner See Remarks | Jun 21, 2023 | Sale | −225 | $0.69 | $155 | 253,511 |
| Martin Brenner See Remarks | Jun 21, 2023 | Sale | −3,859 | $0.68 | $2.62K | 253,736 |
| Martin Brenner See Remarks | May 22, 2023 | Sale | −24 | $0.95 | $23 | 257,595 |
| Martin Brenner See Remarks | May 22, 2023 | Sale | −4,158 | $0.94 | $3.91K | 257,619 |
| Martin Brenner See Remarks | Apr 24, 2023 | Sale | −4,382 | $1.20 | $5.26K | 261,777 |
| Felipe Duran Chief Financial Officer | Mar 31, 2023 | Award | +37,500 | – | – | 39,633 |
| Martin Brenner See Remarks | Mar 31, 2023 | Award | +50,000 | – | – | 266,159 |
| Martin Brenner See Remarks | Mar 23, 2023 | Sale | −5,213 | $2.13 | $11.10K | 216,159 |
| Martin Brenner See Remarks | Feb 21, 2023 | Sale | −3,976 | $1.77 | $7.04K | 221,372 |
| Martin Brenner Interim CEO and CSO | Jan 20, 2023 | Award | +130,000 | – | – | 225,348 |
| Robert Matthew Lutz See Remarks | Nov 11, 2022 | Award | +100,057 | – | – | 102,165 |
| Martin Brenner Chief Scientific Officer | Nov 11, 2022 | Award | +95,348 | – | – | 95,348 |
| Robert Matthew Lutz See Remarks | Mar 10, 2022 | Sale | −24,625 | $0.35 | $8.62K | 207,375 |
| Randy Joe Maddux Chief Operating Officer | Dec 7, 2021 | Sale | −37,243 | $0.68 | $25.33K | 271,757 |
| Robert Matthew Lutz See Remarks | Mar 4, 2021 | Award | +232,000 | – | – | 232,000 |
| Randy Joe Maddux Chief Operating Officer | Dec 1, 2020 | Award | +309,000 | – | – | 309,000 |
| Services Ltd. Portfolio 10% owner | Aug 11, 2020 | Sale | −15,864,436 | $2.92 | $46.32M | 8,629,693 |
| Services Ltd. Portfolio 10% owner | Aug 10, 2020 | Sale | −7,264,864 | $3.91 | $28.41M | 24,494,129 |
| Services Ltd. Portfolio 10% owner | Aug 7, 2020 | Sale | −1,355,604 | $3.83 | $5.19M | 31,758,993 |
| Services Ltd. Portfolio 10% owner | Aug 7, 2020 | Conversion | +28,925,000 | $0.20 | $5.79M | 33,114,597 |
| Capital LTD Eastern 10% owner | Aug 6, 2020 | Sale | −2,768,137 | $4.18 | $11.57M | 33,114,597 |
| Capital LTD Eastern 10% owner | Aug 5, 2020 | Sale | −900,000 | $4.46 | $4.01M | 35,882,734 |
| Capital LTD Eastern 10% owner | Aug 4, 2020 | Sale | −600,000 | $4.39 | $2.63M | 36,782,734 |
| Robert L. Erwin President | Jun 4, 2020 | Sale | −28,268 | $1.71 | $48.34K | 108,108 |
| Robert L. Erwin President | Jun 4, 2020 | Option exercise | +28,268 | $0.93 | $26.29K | 108,108 |
| Robert L. Erwin President | Jun 2, 2020 | Option exercise | +96,124 | $0.93 | $89.40K | 136,376 |
| Robert L. Erwin President | Jun 2, 2020 | Sale | −96,124 | $1.62 | $155.72K | 136,376 |
| James P. Mullaney Chief Financial Officer | May 27, 2020 | Sale | −11,250 | $1.61 | $18.11K | 0 |
| James P. Mullaney Chief Financial Officer | May 27, 2020 | Option exercise | +11,250 | $0.93 | $10.46K | 0 |
| Thomas Francis 3rd Isett CEO and Executive Co-Chairman, Director | Mar 19, 2020 | Conversion | +100,000 | $0.20 | $20.00K | 1,275,000 |
| Thomas Francis 3rd Isett CEO and Executive Co-Chairman, Director | Mar 17, 2020 | Option exercise | +78,024 | $0.22 | $17.17K | 1,275,000 |
| Thomas Francis 3rd Isett CEO and Executive Chairman, Director | Feb 20, 2020 | Other | +121,976 | – | – | 1,275,000 |
| Kenneth Bryan Dart 10% owner | Mar 14, 2019 | Other | +1 | – | – | 1 |
| Kenneth Bryan Dart 10% owner | Mar 14, 2019 | Other | +1 | – | – | 1 |
| Kenneth Bryan Dart 10% owner | Jan 1, 2019 | Other | −1 | – | – | 1 |
| Services Ltd. Portfolio 10% owner | Jul 12, 2018 | Buy | +2,200,000 | $0.90 | $1.98M | 8,457,734 |
| Capital LTD Eastern 10% owner | Jun 26, 2018 | Buy | +1,683,334 | $0.90 | $1.52M | 6,257,734 |
| Services Ltd. Portfolio 10% owner | Nov 30, 2017 | Buy | +12,000,000 | $0.20 | $2.40M | 45,744,000 |
| Kenneth Bryan Dart 10% owner | Feb 23, 2017 | Buy | +1 | – | – | 1 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of iBio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 68,584 shares on Oct 9, 2026 over the last 90 days.
See a number that looks wrong?